Healthcare -
Biotechnology - NASDAQ - US
$ 41.0
1.84 %
$ 3.8 B
Market Cap
-11.08
P/E
CRNX - STOCK-BASED COMPENSATION
Stock-based Compensation CRNX - Crinetics Pharmaceuticals, Inc.
40.9 M
LAST VALUE
53.60%
2 YEAR CAGR
77.55%
5 YEAR CAGR
0.00%
10 YEAR CAGR